Spain· ES:1161109001IP
ZAVICEFTA 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing ceftazidima + avibactam, registered in Spain by Pfizer Ireland Pharmaceuticals Unlimited Company.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- ceftazidima + avibactam
- Manufacturer
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftazidima + avibactam in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- United StatesAVYCAZAllergan, Inc.
- FranceZAVICEFTA 2 g/0,5 g, poudre pour solution à diluer pour perfusionPFIZER IRELAND PHARMACEUTICALS (IRLANDE)
- United KingdomZavicefta 2g/0.5g powder for concentrate for solution for infusion vialsPfizer Ltd
- SwitzerlandZavicefta, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungPfizer AG
- IcelandZaviceftaPfizer Ireland Pharmaceuticals
- NetherlandsZAVICEFTA 2 g/0,5 g, poeder voor concentraat voor oplossing voor infusiePfizer Ireland Pharmaceuticals, Operations Services Group
- NorwayZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zavicefta
- Liechtenstein · Zavicefta
- Norway · Zavicefta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40857d62-7286-4c27-9aa9-b49376c7a578 GET /v1/drugs/40857d62-7286-4c27-9aa9-b49376c7a578?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1783431960000}",
"nregistro": "1161109001IP",
"substance": "ceftazidima + avibactam"
}See everything about ceftazidima + avibactam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.